Baring exits Centro Inmunológico de Cataluna

The 28.4% stake was held by Inveracartera Capital, a fund managed by Baring on behalf of Catalunya Caixa. Financial details were undisclosed.

Labco has acquired a further 3.5% of the company from the management, which retains a 3.2% stake, bringing its share of the company to 31.9%. Juan Carlos Serrat, president of CIC, will retain a 64.9% stake in the company.

Labco is a French medical diagnostics company based in Paris and Brussels and operating in France, Belgium, Spain, Italy and Germany. In 2010, Spanish sales amounted to €90m. The company has grown through acquisitions since its foundation in 2002.

Previous funding
In 2005, Invercartera invested €3.3m in exchange for a 31.9% stake, which it later reduced to 28.4%.

Company
Founded in 1982 and based in Barcelona, CIC is a clinic analysis and diagnostics service provider. In 2010 the company reported a €10m turnover, which it aims to increase through international expansion. The firm has subsidiary companies in Brazil and Colombia and premises in Lebanon. 60% of its sales originate in Latin America.

People
Juan Carlos Serrat is president of CIC.

Advisers
Acquiror – Fornesa Prada Fernández Abogados (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Healthcare
• Exits
• Spain